<DOC>
	<DOCNO>NCT00185159</DOCNO>
	<brief_summary>This study diabetic patient least one additional cardiovascular risk factor normoalbuminuria prior randomization .</brief_summary>
	<brief_title>Olmesartan Medoxomil Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>Diabetes mellitus type 2 , define fast blood glucose great equal 126 mg/dL ; Presence least one follow cardiovascular risk factor : 1. total cholesterol great 200 mg/dL statin treatment , 2 . High density lipoprotein ( HDL ) less 40 mg/dL , 3. triglyceride great 150 mg/dL less 400 mg/dL , 4. blood pressure great equal 130/80 mmHg , 5 . Body mass index ( BMI ) great 28 kg/m2 , 6. waist circumference great 102 cm men great 88 cm woman , 7. smoking 5 cigarette day ; Normoalbuminuria screen Severe uncontrolled hyperlipidemia ; Documented renal and/or renalvascular disease ; Myocardial infarction , stroke myocardial revascularization within last 6 month ; History alcohol and/or drug abuse ; Allergic reaction , lack response contraindication angiotensin receptor blocker ( ARBs ) ; Current treatment ARB angiotensin convert enzyme ( ACE ) inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Microalbuminuria</keyword>
</DOC>